RT @TomsCe: Roam has now partnered with 1000+ of the biggest gaming & livestream creators. We just raised a stealth pre-seed from great inv….

RT @InsaneAmbition_: "Blockchain is essentially a decentralised ledger", Liam says!.Watch the entire podcast here:.💜 Apple Pod: https://t.c….

RT @ankurnagpal: I spent the last month living and working from Buenos Aires instead of our office in Brooklyn. Two observations:. 1 - Life….

Plane hustle hits different

Sora just checkmated me. I was very unprepared for this. The only question is how did they pull this off?.

History never repeats itself but it rhymes. Had an awesome chat with Andrew Nash, CSO of CSL, Australia’s largest biotech company, who also just happens to be a history buff. Link to full episode in thread. 👇

I’m asking for $30m to build super soldiers and preserve US hegemony through protein and genome design. You in, @DARPA?

Insane.

RT @JuliusYRitter: Welcome to Longevity Castle San Francisco - The Antidote to Hackerhouses. We’re rethinking health-focused co-living fro….

Sat down with Tim Springer from @Harvard today to discuss his experience as the co-founder of five successful biotech companies and as founding investor of @moderna_tx. Tim calls himself lucky. But this is more than dumb luck. Success is reproducible. We’re very grateful.

Decades before technologies like ChatGPT and LLMs gained widespread attention, Eduard Hovy decided to undertake a PhD in AI and Computer Science at Yale University. I sat down with him to talk about LLMs, ChatGPT and the Future of Humanity.

Just had a 1hr chat with Prof Jim Collins of @MIT about explainable, deep learning approaches to small molecule and small RNA design. I increasingly believe that RNA molecule design with end functionality in mind will be a paradigm-shift for creating biosensor aptamer tech.